Chemokine Lkn-1/CCL15 enhances matrix metalloproteinase-9 release from human macrophages and macrophage-derived foam cells
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Atherosclerosis is characterized by a chronic inflammatory disease, and chemokines play an important role in both initiation and progression of atherosclerosis development. Leukotactin-1 (Lkn-1/CCL15), a new member of the human CC chemokine family, is a potent chemoattractant for leukocytes. Our previous study has demonstrated that Lkn-1/CCL15 plays a role in the initiation of atherosclerosis, however, little is currently known whether Lkn-1/CCL15 is associated with the progression of atherosclerosis. Matrix metalloproteinases (MMPs) in human coronary atherosclerotic lesions play a crucial role in the progression of atherosclerosis by altering the vulnerability of plaque rupture. In the present study, we examined whether Lkn-1/CCL15 modulates MMP-9 release, which is a prevalent form expressed by activated macrophages and foam cells. Human THP-1 monocytic cells and/or human peripheral blood monocytes (PBMC) were treated with phorbol myristate acetate to induce their differentiation into macrophages. Foam cells were prepared by the treatment of THP-1 macrophages with human oxidized LDL. The macrophages and foam cells were treated with Lkn-1/CCL15, and the levels of MMP-9 release were measured by Gelatin Zymography. Lkn-1/CCL15 significantly enhanced the levels of MMP-9 protein secretion from THP-1 monocytic cells-derived macrophages, human PBMC-derived macrophages, as well as macrophage-derived foam cell in a dose dependent manner. Our data suggest that the action of Lkn-1/CCL15 on macrophages and foam cells to release MMP-9 may contribute to plaque destabilization in the progression of atherosclerosis.
Abstract
Atherosclerosis is characterized by a chronic inflammatory disease, and chemokines play an important role in both initiation and progression of atherosclerosis development. Leukotactin-1 (Lkn-1/CCL15), a new member of the human CC chemokine family, is a potent chemoattractant for leukocytes. Our previous study has demonstrated that Lkn-1/CCL15 plays a role in the initiation of atherosclerosis, however, little is currently known whether Lkn-1/CCL15 is associated with the progression of atherosclerosis. Matrix metalloproteinases (MMPs) in human coronary atherosclerotic lesions play a crucial role in the progression of atherosclerosis by altering the vulnerability of plaque rupture. In the present study, we examined whether Lkn-1/CCL15 modulates MMP-9 release, which is a prevalent form expressed by activated macrophages and foam cells. Human THP-1 monocytic cells and/or human peripheral blood monocytes (PBMC) were treated with phorbol myristate acetate to induce their differentiation into macrophages. Foam cells were prepared by the treatment of THP-1 macrophages with human oxidized LDL. The macrophages and foam cells were treated with Lkn-1/CCL15, and the levels of MMP-9 release were measured by Gelatin Zymography. Lkn-1/CCL15 significantly enhanced the levels of MMP-9 protein secretion from THP-1 monocytic cells-derived macrophages, human PBMC-derived macrophages, as well as macrophage-derived foam cell in a dose dependent manner. Our data suggest that the action of Lkn-1/CCL15 on macrophages and foam cells to release MMP-9 may contribute to plaque destabilization in the progression of atherosclerosis.
참고문헌 (12)
- Boyle JJ, "Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture", Curr Vasc Pharmacol, 3, pp.63~68 (2005)
- Galis ZS, "Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly", Circ Res, 90, pp.251~262 (2002)
- Kodali R, "Chemokines induce matrix metalloproteinase- 2 through activation of epidermal growth factor receptor in arterial smooth muscle cells", Cardiovasc Res, 69, pp.706~715 (2006)
- Lee WH, "A novel chemokine, Leukotactin-1, induces chemotaxis, pro-atherogenic cytokines, and tissue factor expression in atherosclerosis", Atherosclerosis, 161, pp.255~260 (2002)
- Libby P, "Inflammation in atherosclerosis", Nature, 420, pp.868~874q (2002)
- Mann JM, "Vulnerable plaque. Relation of characteristics to degree of stenosis in human coronary arteries", Circulation, 94, pp.928~931 (1996)
- Newby AC, "Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture", Physiol Rev, 85, pp.1~31 (2005)
- Pasterkamp G, "Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery", Atherosclerosis, 150, pp.245~253 (2000)
- Reape TJ, "Chemokines and atherosclerosis", Atherosclerosis, 147, pp.213~225 (1999)
- Sheikine Y, "Chemokines and atherosclerosis", Ann Med, 36, pp.98~118 (2004)
- Shin WS, "The role of chemokines in human cardiovascular pathology: enhanced biological insights", Atherosclerosis, 160, pp.91~102 (2002)
- Yu R, "Involvement of leukotactin-1, a novel CC chemokine, in human atherosclerosis", Atherosclerosis, 174, pp.35~42 (2004)